Related references
Note: Only part of the references are listed.Relationship between discharge heart rate and mortality in patients after acute myocardial infarction treated with primary percutaneous coronary intervention
M. Louisa Antoni et al.
EUROPEAN HEART JOURNAL (2012)
Usefulness of Heart Rate at Rest as a Predictor of Mortality, Hospitalization for Heart Failure, Myocardial Infarction, and Stroke in Patients With Stable Coronary Heart Disease (Data from the Treating to New Targets [TNT] Trial)
Jennifer E. Ho et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Optimal Medical Therapy for Non-ST-Segment-Elevation Acute Coronary Syndromes Exploring Why Physicians Do Not Prescribe Evidence-Based Treatment and Why Patients Discontinue Medications After Discharge
Alan J. Bagnall et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2010)
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
Michael Boehm et al.
LANCET (2010)
Inadequate control of heart rate in patients with stable angina: results from the European Heart Survey
Caroline A. Daly et al.
POSTGRADUATE MEDICAL JOURNAL (2010)
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial
Kim Fox et al.
EUROPEAN HEART JOURNAL (2009)
Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial
Jean-Claude Tardif et al.
EUROPEAN HEART JOURNAL (2009)
Heart rate management in coronary artery disease: the CLARIFY registry
Philippe Gabriel Steg
EUROPEAN HEART JOURNAL SUPPLEMENTS (2009)
Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study
Judith Hsia et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
Kim Fox et al.
LANCET (2008)
Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial
Kim Fox et al.
LANCET (2008)
Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST)
Rainer Kolloch et al.
EUROPEAN HEART JOURNAL (2008)
2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina
Theodore D. Fraker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Resting heart rate in cardiovascular disease
Kim Fox et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
External validity of clinical trials in acute myocardial infarction
Philippe Gabriel Steg et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Guidelines on the management of stable angina pectoris: executive summary
Kim Fox et al.
EUROPEAN HEART JOURNAL (2006)
Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina
JC Tardif et al.
EUROPEAN HEART JOURNAL (2005)
Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease
A Diaz et al.
EUROPEAN HEART JOURNAL (2005)
Treating Individuals 1 - External validity of randomised controlled trials: To whom do the results of this trial apply?'
PM Rothwell
LANCET (2005)
Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina -: A randomized, double-blind, multicentered, placebo-controlled trial
JS Borer et al.
CIRCULATION (2003)
Share Paper
